Discussion
For seven years, I have kept up on developments in multiple myeloma research. I follow the latest treatments, the newest studies, and…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Discussion
For seven years, I have kept up on developments in multiple myeloma research. I follow the latest treatments, the newest studies, and…
Discussion
The U.S. Food and Drug Administration (FDA) has approved a new version of Sarclisa (isatuximab), an approved treatment for multiple myeloma sold by…
Discussion
Regulatory authorities in two countries have given the green light for clinical testing of a novel treatment from Mabwell Bioscience — which the company…
Discussion
I find myself watching my mother’s hands more often these days. It shouldn’t come as a surprise, though. After all, observation is one of…
Discussion
A protein called IRF2 may help drive myeloma, and measuring its levels could help predict outcomes among people with the blood cancer, a new…
Discussion
Some nights I sit beside my mum’s bed and look back on the four years since her myeloma diagnosis. I find it hard to…
Don't have an account?
|
Already have an account?
Create your account by filling in the information below:
By creating an account, you are agreeing to the Privacy Policy and Terms of Service.